Mathew S. Maurer MDArnold and Arlene Goldstein Professor of Cardiology; Professor of Medicine; Director, Clinical Cardiovascular Research Laboratory for the Elderly; Director, Cardiac Amyloidosis Program, Columbia University Irving Medical Center, New York Presbyterian Hospital – Columbia Campus, New York, New York
Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus.
He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults.
Dr. Maurer receives grant support from NIH R01HL139671, R21AG058348, and K24AG036778; consulting income from Pfizer, Eidos, Prothena, Akcea and Alnylam, Intellia, GSK; and institutional support in the form of clinical trial funding from Pfizer, Prothena, Eidos and Alnylam.